BioPharma Resources

Drug Trial Radar · NCT07705555

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Title says "pivotal". Randomized with 960 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

960

Planned (sponsor's estimate)

Start

Aug 27, 2026

Primary completion

Oct 31, 2028

Study completion Oct 31, 2029

Sponsor

Lead sponsor
Merck Sharp & Dohme LLCMerck & Co. (MRK)
Sponsor type
Industry
First posted
Jul 15, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can treat DME. An available standard (usual) treatment for DME is aflibercept. However, standard treatments such as aflibercept may not work for every person. The main goal of this trial is to learn if MK-8748 works as well as aflibercept to treat DME.

Conditions

  • Diabetic Retinopathy
  • Macular Edema

Interventions

  • MK-8748Drug

    Administered by intravitreal injection (IVT)

  • AfliberceptDrug

    Administered by intravitreal injection (IVT)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change in Best-Corrected Visual Acuity (BCVA) (Early Treatment of Diabetic Retinopathy Study [ETDRS] Letters) From Baseline to Year 1Time frame: Baseline and 1 Year

Locations

45 sites in 4 countries. Site status is shown where the registry gives one.

  • Associated Retina Consultants, Ltd ( Site 0084)

    Gilbert, Arizona · Recruiting

  • Global Research Management ( Site 0066)

    Glendale, California · Recruiting

  • Retinal Consultants Medical Group ( Site 0013)

    Sacramento, California · Recruiting

  • Retina Specialists of Colorado ( Site 0068)

    Denver, Colorado · Recruiting

  • Retina Consultants ( Site 0065)

    Manchester, Connecticut · Recruiting

  • Vitreo Retinal Associates ( Site 0042)

    Gainesville, Florida · Recruiting

  • Retina Care Specialists ( Site 0095)

    Palm Beach Gardens, Florida · Recruiting

  • Retina Vitreous Associates of Florida ( Site 0034)

    Tampa, Florida · Recruiting

  • Florida Retina Institute ( Site 0105)

    Wildwood, Florida · Recruiting

  • Midwest Eye Institute ( Site 0113)

    Carmel, Indiana · Recruiting

  • Retina Associates LLC ( Site 0024)

    Lenexa, Kansas · Recruiting

  • Mid Atlantic Retina ( Site 0062)

    Hagerstown, Maryland · Recruiting

  • Retina Specialists ( Site 0074)

    Towson, Maryland · Recruiting

  • New England Retina Consultants ( Site 0020)

    Springfield, Massachusetts · Recruiting

  • Mississippi Retina Associates, P.A. ( Site 0061)

    Madison, Mississippi · Recruiting

  • Envision Ocular, LLC ( Site 0039)

    Bloomfield, New Jersey · Recruiting

  • Mid Atlantic Retina ( Site 0048)

    Cherry Hill, New Jersey · Recruiting

  • Retina Associates of Western NY, PC ( Site 0038)

    Rochester, New York · Recruiting

  • Asheville Eye Associates ( Site 0058)

    Asheville, North Carolina · Recruiting

  • North Carolina Retina Associates ( Site 0064)

    Wake Forest, North Carolina · Recruiting

  • Cincinnati Eye Institute ( Site 0108)

    Cincinnati, Ohio · Recruiting

  • Charleston Neuroscience Institute ( Site 0087)

    Bluffton, South Carolina · Recruiting

  • Palmetto Retina Center ( Site 0063)

    Florence, South Carolina · Recruiting

  • Charleston Neuroscience Institute ( Site 0022)

    Mt. Pleasant, South Carolina · Recruiting

  • Palmetto Retina Center ( Site 0014)

    West Columbia, South Carolina · Recruiting

  • Southeastern Retina Associates PC ( Site 0072)

    Hixson, Tennessee · Recruiting

  • Southeastern Retina Associates PC ( Site 0071)

    Johnson City, Tennessee · Recruiting

  • Southeastern Retina Associates PC ( Site 0018)

    Knoxville, Tennessee · Recruiting

  • Austin Research Center for Retina ( Site 0033)

    Austin, Texas · Recruiting

  • Austin Retina Associates ( Site 0008)

    Austin, Texas · Recruiting

  • Retina Consultants of Texas ( Site 0001)

    Bellaire, Texas · Recruiting

  • Texas Retina Associates ( Site 0025)

    Plano, Texas · Recruiting

  • Austin Retina Associates ( Site 0080)

    San Marcos, Texas · Recruiting

  • Retina Consultants of Texas ( Site 0029)

    Schertz, Texas · Recruiting

  • Retina Consultants of Texas ( Site 0010)

    The Woodlands, Texas · Recruiting

  • Piedmont Eye Center, Inc. ( Site 0041)

    Lynchburg, Virginia · Recruiting

  • Retina Consultants ( Site 0104)

    Charleston, West Virginia · Recruiting

  • Fundacion Zambrano ( Site 0402)

    CABA, Argentina · Recruiting

  • Oftar Mendoza ( Site 0416)

    Mendoza, Argentina · Recruiting

  • Centro de Ojos Quilmes ( Site 0413)

    Quilmes, Buenos Aires, Argentina · Recruiting

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.